company tower banner
ROELMI HPC Company Logo

BeautySYN® Bright

1 of 2 products in this brand
BeautySYN® Bright is an innovative slow release system leading to improve stability of active molecules and slowly release with long lasting

INCI Name: Dextran, Origanum Vulgare Leaf Extract, Potassium Sorbate, Sodium Benzoate

Functions: Antioxidant, Brightening Agent

Labeling Claims: Allergen-free, Amine-free, BSE-free, Chelate-free, Ethanol-free, Ethylene Oxide-free, Formaldehyde-free, GMO-free, Glycol ether-free, Nanomaterials-free, Not Tested on Animals, Pesticide-free, Phthalates-free, Protein-free, Stabilizers-free, TSE-free, Ulta Beauty's Conscious Beauty, VOC-free

Benefit Claims: Age & Dark Spot Reduction, Antioxidant Properties, Brightening, Even Skin Tone, Long Lasting, Shine & Radiance

Certifications & Compliance: REACH (Europe)

Knowde Enhanced TDS

Identification & Functionality

Cosmetic Ingredients Functions

Features & Benefits

Product Highlights
  • Powerful antioxidant polymeric conjugates designed to even skin tone
  • Patented conjugation technology, innovative & soft
  • Performing active to improve skin global brightening effect
  • Improvement of overall skin complexion
  • Improvement of skin radiance, reduction of skin dark spots
  • Available Saf-e-cacy® dossier on Safety & efficacy

Applications & Uses

Application Format
Skin Care Applications
Use Level
1.0%
Typical Applications
  • Lightening emulsions
  • Brightening and radiant serums
  • Anti-aging creams
  • Mature skins
  • Correction of dark spots

Properties

Physical Form
Appearance
Liquid
Odor
Characteristic

Regulatory & Compliance

Certifications & Compliance

Technical Details & Test Data

In-vitro efficacy dossier: evaluation of Tyrosinase inhibition
  • Evaluation of the lightening activity by Tyrosinase inhibition
  • Compared to Dextran and to free polyphenols, which are less effective, BeautySYN® Bright is able to inhibit Tyrosinase up to 99%
  • BeautySYN® technology shows better results than the sum of single elements

ROELMI HPC BeautySYN Bright In-vitro efficacy dossier: evaluation of Tyrosinase inhibition

In-vivo efficacy dossier: improvement of skin radiance
  • Evaluation of the skin lightness / radiance improvement
  • After 30 and 60 days of use and compared to placebo, BeautySYN® Bright shows a significant increase of skin radiance g (gloss) up to 14. 2%

ROELMI HPC BeautySYN Bright In-vivo efficacy dossier: improvement of skin radiance

In-vivo efficacy dossier: reduction of dark spots staining
  • Evaluation of the intensity of dark spots staining
  • After 30 and 60 days of use and compared to placebo, BeautySYN® Bright determines a significant reduction of dark spots staining up to -51.3%

ROELMI HPC BeautySYN Bright In-vivo efficacy dossier: reduction of dark spots staining

Test Data

In-vitro test: DPPH assay, Tyrosinase inhibition
In-vivo test: dark spots staining, skin radiance, skin redness
Dermatologist assessment: appearance of dark spots, skin brightness
Efficacy control: inhibition of Tyrosinase activity (at every batch)

Storage & Handling

Shelf Life
24 months
Storage
Keep the product in the original container well closed in fresh and dry place, repaired from humidity, light or heat sources.